用免疫检查点抑制剂治疗各种癌症患者的免疫相关不良事件的模式
Matthew J Slaught1, Dalia Kaakour2, Armon Azizi1
1University of California Irvine School of Medicine, Irvine, CA, USA.
Future oncology (London, England)
|December 21, 2025
概括
主要癌症类型在接受免疫检查点抑制剂 (ICI) 的患者中没有预测免疫相关不良事件 (irAEs). 与单一治疗相比,组合疗法导致更早的irAE发作.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫检查点抑制剂 (ICI) 利用免疫系统对抗癌症.
- 与免疫相关的不良事件 (irAEs) 是ICI的常见副作用.
- 了解irAE模式对于患者管理至关重要.
研究的目的:
- 确定原发性癌症类型是否影响受irAEs影响的组织.
- 为了比较不同ICI方案之间的irAE发病率和时间.
主要方法:
- 对241名用ICI治疗的患者进行了回顾性图表审查.
- 在一个机构对262条治疗线进行分析.
- 基于癌症类型和ICI组合的irAE发生率的比较.
主要成果:
- 在原发性癌症类型和组织特异性irrAEs之间没有发现显著的关联.
- 联合使用PD-1/CTLA-4抑制剂 (61%) 和单独使用PD-1抑制剂 (46%) 的irAE发病率较高.
- 联合治疗 (2.30个月) 与单一治疗 (7.88个月) 的中位时间到第一次irAE显著缩短.
结论:
- 主要癌症类型不能预测接受ICI的患者的irAE模式.
- 组合ICI治疗导致较早的irAE发作,需要调整监测.
- 需要进一步的研究来确定针对个性化患者护理的irAEs的预测因子.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


